Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer
- DOI
- 10.1038/s41523-025-00842-8
- Published
- 2025-11-21
- Container
- npj Breast Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-025-00842-8,
title = {Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer},
author = {Laura A. Huppert and Amelia S. Gliwa and Madeline Tait and Laura Quintal and Stephanie Starzinski and Alexander Cheung and Mark Moasser and Melanie Majure and Michelle Melisko and Pamela Munster and Hope S. Rugo and Michael Campbell and Lawrence Fong and A. Jo Chien},
year = {2025},
journal = {npj Breast Cancer},
doi = {10.1038/s41523-025-00842-8},
url = {https://doi.org/10.1038/s41523-025-00842-8}
}RIS
TY - JOUR TI - Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer AU - Laura A. Huppert AU - Amelia S. Gliwa AU - Madeline Tait AU - Laura Quintal AU - Stephanie Starzinski AU - Alexander Cheung AU - Mark Moasser AU - Melanie Majure AU - Michelle Melisko AU - Pamela Munster AU - Hope S. Rugo AU - Michael Campbell AU - Lawrence Fong AU - A. Jo Chien PY - 2025 JO - npj Breast Cancer DO - 10.1038/s41523-025-00842-8 UR - https://doi.org/10.1038/s41523-025-00842-8 ER -
APA
Huppert, L. A., Gliwa, A. S., Tait, M., Quintal, L., Starzinski, S., Cheung, A., Moasser, M., Majure, M., Melisko, M., Munster, P., Rugo, H. S., Campbell, M., Fong, L., & Chien, A. J. (2025). Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer. npj Breast Cancer. https://doi.org/10.1038/s41523-025-00842-8
Source records
- crossref · retrieved 2026-09-25T22:56:30.320Z